Description
Phase
Phase 4 - refines the treatment to become part of standard care.Inclusion and Exclusion Criteria
Please contact Valentina Rodina to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Salix Site, Long Beach, California, 90822
- Inland Empire Liver Foundation, Rialto, California, 92377
- Salix Site, Riverside, California, 92501
- UCSD Clinical & Translational Research Institute, La Jolla, California, 92037
- Salix Site, San Diego, California, 92103
- Southern California Liver Centers, Coronado, California, 92118
- UCSF/Fresno - CRMC, Fresno, California, 93721
- Salix Site, San Francisco, California, 94115
-
Arizona
- Banner Research, Phoenix, Arizona, 85016
-
Utah
- University of Utah Hospital, Salt Lake City, Utah, 84132
-
Colorado
- University of Colorado Denver, Aurora, Colorado, 80045
-
Texas
- Salix Site, Odessa, Texas, 79761
- Methodist Hospital, San Antonio, Texas, 78229
- Alamo Medical Research, San Antonio, Texas, 78215
- Amcare Research Inc, Houston, Texas, 77090
- Research Specialists of Texas, Houston, Texas, 77030
-
Oklahoma
- Integris Nazh Zuhdi Transplant Institute, Oklahoma City, Oklahoma, 73112
-
Missouri
- Kansas City Research Institute, Kansas City, Missouri, 64131
- St. Louis University, St. Louis, Missouri, 63104
-
Louisiana
- Delta Research Partners, LLC, Monroe, Louisiana, 71201
- Salix Site, Jefferson, Louisiana, 70124
-
Minnesota
- Mayo Clinic, Rochester, Minnesota, 55905
-
Wisconsin
- University of Wisconsin Hospital & Clinics, Madison, Wisconsin, 53792
-
Illinois
- Salix Site, Chicago, Illinois, 60611
-
Indiana
- Indiana University, Indianapolis, Indiana, 46202
Powered by
SC CTSI